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Research
Lead has long been known to be a hazard to 
the human brain and nervous system based on 
data from epidemiologic studies (Castellino 
et al. 1995). Because leaded gasoline has been 
phased out and environmental levels of lead 
have been reduced, recent investigations have 
focused on subclinical damage and health 
effects of chronic exposure that do not result 
in the typical symptoms and signs. Typically, 
blood lead levels are measured. For exam-
ple, studies of workers with low to moderate 
blood lead levels have reported abnormal elec-
trophysiologic parameters and neurobehav-
ioral performance (Baker et al. 1984; Chuang 
et al. 2000, 2005; Jeyaratnam et al. 1985; 
Lucchini et al. 2000). More recently, X-ray 
fluorescence (XRF) is being used to non-
invasively measure the accumulation of lead 
in bones. Often the tibia and the patella are 
studied (Hu et al. 1995, 1998). Lead accu-
mulation in the tibia, a cortical bone, can 
serve as a biomarker of cumulative lead dose, 
and there lead has a residual half-life of 25–30 
years. Lead accumulation in the patella, a tra-
becular bone, has a half-life clearance ranging 
from months to years and is considered to be 
a biomarker for both accumulation and short-
term bioavailability.
Identifying such subclinical changes in 
workers chronically exposed to lower levels 
of lead is important because brain damage 
occurs slowly. Neurobehavioral tests, which 
are now the method of determining whether 
lead exposure has affected brain function-
ing (Baker et al. 1984; Chuang et al. 2005; 
Lucchini et al. 2000), are somewhat slow 
because they measure an outcome of brain 
damage. Few studies have examined the 
mechanism or biochemical changes caused 
by lead in the human brain, although recently 
some have used magnetic resonance spectros-
copy (MRS) to test brain metabolism in vivo 
(Meng et al. 2005; Trope et al. 1998, 2001; 
Weisskopf et al. 2004, 2007a).
MRS is a noninvasive method of exam-
ining the biochemical aspects of neurologic 
disease in vivo. The development of spatially 
localized spectroscopic methods that sample 
the relative levels of metabolites from the vol-
ume of tissues defined from magnetic reso-
nance imaging (MRI) scanning has provided 
the basis for integrating the biochemical 
information with anatomical information 
obtained from the MRI (Cox 1996; Ross et al. 
2006). MRS has been used to assess both 
neuronal viability and demyelination (Burlina 
et al. 2000; Ross et al. 2006). Although its 
use for the study of neurologic diseases has 
grown rapidly over the past decade, its use for 
investigating environmental insult to human 
brains is quite new (Weisskopf et al. 2007a).
Because brains of children are very vulner-
able to lead exposure (Castellino et al. 1995), 
the brain metabolites of children exposed to 
high levels of lead have been found by MRS 
studies to have abnormalities (Meng et al. 
2005; Trope et al. 1998, 2001). Recently, 
the Veterans Normative Aging Study, a 
  community-based cohort of elderly U.S. 
men, reported an association between bone 
lead and increased myoinositol-to-creatine 
ratio in 31 people with a mean age of 77 
years (Weisskopf et al. 2007a). However, to 
our knowledge, little research has used this 
approach on highly exposed adults such as 
lead workers. Thus, in this in vivo study we 
used MRS as well as traditional measures of 
lead levels and a survey, to study the effects of 
long-term lead exposure on brain metabolism 
in a group of lead workers and age- and sex-
matched nonexposed controls.
Materials and Methods
Participants. We conducted this study in a 
lead paint factory, where workers were required 
by law to receive annual health examinations. 
We enrolled 22 lead-exposed workers and 
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Ba c k g r o u n d: Lead is known to be a health hazard to the human brain and nervous system based 
on data from epidemiologic studies. However, few studies have examined the mechanism or bio-
chemical changes caused by lead in the human brain, although recently some have used magnetic 
resonance spectroscopy (MRS) to test brain metabolism in vivo.
oBjectives: In this study, we used 3-T MRS to investigate brain metabolism in workers chronically 
exposed to lead and matched nonexposed controls.
Ma t e r i a l s and Me t h o d s : Twenty-two workers at a lead paint factory served as chronically exposed 
subjects of this study. These workers did not have any clinical syndromes. Eighteen age- and sex-
matched nonexposed healthy volunteers served as controls. We measured blood and bone lead and 
used a 3-T MRS to measure their levels of brain N-acetyl aspartate (NAA), choline (Cho), and total 
creatine (tCr). A structural questionnaire was used to collect demographic, work, and health histo-
ries and information about their life habits.
re s u l t s: All the MRS measures were lower in the lead-exposed group. Increased blood and bone 
lead levels correlated with declines in Cho:tCr ratios, especially in the occipital lobe, where changes 
in all gray, subcortical, and white matter were significant. Increases in blood and patella lead in 
every layer of the frontal lobe correlated with significant decreases in NAA:tCr ratios. One of 
the strongest regression coefficients was –0.023 (SE = 0.005, p < 0.001), which was found in the 
NAA:tCr ratio of frontal gray matter.
discussion: We conclude that chronic exposure to lead might upset brain metabolism, especially 
NAA:tCr and Cho:tCr ratios. Brain NAA and Cho are negatively correlated to blood and bone 
lead levels, suggesting that lead induces neuronal and axonal damage or loss. The most significant 
changes occurred in frontal and occipital lobes, areas in which previous neurobehavioral studies 
have shown memory and visual performance to be adversely affected by lead toxicity.
key w o r d s : bone lead KXRF, brain metabolism, lead, proton magnetic resonance spectroscopy. 
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18 healthy volunteers. The lead workers came 
from a paint factory that had 30 employees, 
and we included all eligible lead-exposed work-
ers, except one female who was pregnant and 
seven employees who worked in business and 
sales and were not present in the factory dur-
ing the examination days. The 18 nonexposed 
healthy controls volunteered when we posted 
an open announcement in the same area but 
at different plants in industries that did not 
use lead; thus, their socioeconomic status 
was similar to the lead workers. We excluded 
all participants with a history of alcoholism, 
drug abuse, and major neurologic disorders, 
such as severe head injury, stroke, or epilepsy. 
The protocol for this study was approved by 
the Institutional Review Board of Kaohsiung 
Medical University, and we obtained informed 
consent from each participant.
Blood and bone lead measurements. On 
the same day as the MRI study, we took 
blood samples, measured bone lead levels, and 
administered the questionnaires. The blood 
samples were obtained by venipuncture and 
analyzed for whole-blood lead levels using 
a Zeeman-effect graphite furnace atomic 
absorption spectrometer (5100 PC with AS 
60 autosampler; Perkin-Elmer, Waltham, 
MA, USA) in the same laboratory. For intral-
aboratory quality control, standard commer-
cial materials (Betherning Institute, Bio-Rad; 
Hercules, CA, USA) were used, and all coef-
ficients of variation were < 3%.
We examined the bone lead levels at two 
anatomic sites, the right middle tibia and 
the right patella, in vivo using K-shell XRF 
(KXRF) (Canberra Industries, Inc., Meriden, 
CT, USA). The middle tibia and patella 
were representative of primarily cortical and 
trabecular bones, respectively. Cortical and 
trabecular bones have different kinetics with 
respect to bone lead, which probably reflects 
differing architectures and bone dynamics. 
This phenomenon has been demonstrated 
directly by the differences in bone uptake and 
release of lead over time in follow-up KXRF 
studies comparing the two bone types (Tsaih 
et al. 2001). This painless, noninvasive mea-
surement was performed for 30 min at each 
skeletal location. Radiation dosimetry studies 
of dose to skin, bone red marrow, and the 
pelvic area have demonstrated that a typical 
109Cd KXRF measurement gives extremely 
low effective dose values of < 1 microsievert 
(µSv), significantly below the proposed limit 
of negligibility of 10 µSv (Hu et al. 1998; 
Somervaille et al. 1988; Todd et al. 1992).
On the same day, the participants 
answered questionnaires that contained items 
regarding sex, age, health status, occupation, 
educational level, body mass index (BMI), 
and lifestyle habits, including smoking, drink-
ing, and the chewing of betel nut.
MRI and MRS. We examined all patients 
using a 3.0-T whole-body magnetic reso-
nance system (General Electric Company, 
Milwaukee, WI, USA) with a 40 mT/m 
maximum gradient capability. A head coil 
for conventional MRI and proton MRS was 
used. To evaluate the anatomic structures, 
before they underwent proton MRS, both 
the patient and control groups underwent 
conventional magnetic resonance proto-
cols, including fast spin-echo T2-weighted 
(T2W) axial images [repetition time (TR), 
4,000 msec; echo time (TE), 102 msec; 
field of view (FOV), 240 mm × 240 mm; 
thickness, 5 mm], fluid-attenuated inversion 
recovery (FLAIR) T2W axial images (TR, 
8,627 msec; TE, 157.5 msec; inversion time, 
2,100 msec; FOV, 240 mm × 240 mm; thick-
ness, 5 mm), diffusion-weighted images (TR, 
8,000 msec; TE, 71.7 msec; FOV, 240 mm 
× 240 mm; thickness, 5 mm; b-value, 1,000) 
with apparent diffusion coefficient (ADC) 
and enhanced ADC mapping, and FLAIR 
T1-weighted axial images (TR, 1,800 msec; 
TE, 9.8 msec; inversion time, 2,100 msec; 
FOV, 240 mm × 240 mm; thickness, 5 mm).
We used a two-dimensional MRS imag-
ing sequence with point-resolved spectro-
scopy (PRESS) volume preselection. The 
slice (thickness 15 mm) was transverse ori-
ented. We examined three regions: frontal 
lobe, occipitoparietal lobe, and basal ganglia 
regions (Figure 1). Position and size of the 
PRESS box with outer volume suppressed 
were adjusted to partly exclude subcutaneous 
fat without excluding brain tissue. Four addi-
tional saturation bands were used to reduce 
string lipid signals from outside the volume 
of interest (VOI). We accomplished water 
suppression using three preceding chemical 
shift selective saturation (CHESS) pulses. 
Field homogeneity was optimized automati-
cally over the selected VOI by observing the 
water signal. Spectra were acquired with TR 
1,500 msec, TE 144 msec, and a matrix size 
of 16 × 16 over an FOV of 16 cm, resulting 
in a scan time of 6.4 min for each region.
We performed postprocessing of the MRS 
imaging data sets using the Functool soft-
ware package version 2.2.49 (General Electric 
Company). Spectral data sets were zero filled 
to 1,024 points, multiplied by a 1.25-Hz 
Lorentzian function, and Fourier transformed 
in a time domain and in two spatial domains. 
Marquardt curve fitting was performed by 
using a Gaussian line shape to calculate 
the area under the peak for the metabolites 
N-acetyl aspartate (NAA), total creatine (tCr), 
and choline (Cho). We calculated the peak 
area ratios of Cho:tCr and NAA:tCr.
One trained rater, who was blind to the 
subject group status when the measurements 
were performed, conducted the choice of the 
voxels in all areas. Three voxels in each loca-
tion, including gray matter, subcortical white 
matter, and deep white matter of the frontal 
lobes, the occipital lobes, and the basal gan-
glia, were carefully chosen. We used mean 
values for analysis.
Statistical analyses. To summarize data, 
we used descriptive statistics to calculate the 
means of the continuous variables age, work-
ing duration (in years), BMI, blood lead lev-
els, and bone lead levels. We used descriptive 
rates and proportions for categorical variables 
such as sex and uses of tobacco, alcohol, and 
betel nut. t-Tests were used to compare dif-
ferences in continuous variables between the 
two groups, and the chi-square or Fisher exact 
tests were used to test differences in nominal 
variables between the two groups. Multiple  Figure 1. The measurement of MRS in vivo. (A) Basal ganglion. (B) Frontal lobe. (C) Occipital lobe.
A B CThe effect of lead on brain proton MRS
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linear regressions were used to test the associa-
tion between each MRS measure and each lead 
parameter, with adjustment for sex, age, and 
smoking status. Because the units of blood and 
bone lead levels were different, we compared 
the effect using standardized regression coeffi-
cients. All statistics operations were performed 
with SPSS software (version 14.0.0; SPSS, 
Inc., Chicago, IL, USA). p-Values < 0.05 (two-
tailed) were considered significant.
Results
Table 1 shows all the blood and bone (tibia 
and patella) lead levels. The mean ± SD of 
blood and bone lead levels in exposed group 
were 16.99 ± 10.38 µg/dL, 61.55 ± 30.21 µg/g 
tibia bone minerals, and 66.29 ± 19.48 µg/g 
patella bone minerals, respectively, and in 
the nonexposed controls, 3.4 ± 1.11 µg/
dL, 18.51 ± 22.4 µg/g tibia bone minerals, 
and 7.14 ± 9.81 µg/g patella bone minerals, 
respectively. The Pearson correlation coeffi-
cients were 0.588 (p < 0.001) between patella 
and tibia lead, 0.685 (p < 0.001) between 
patella and blood, and 0.544 (p < 0.001) 
between tibia and blood lead levels.
The exposure and nonexposure groups had 
similar age, BMIs, and life habits. Although 
the study group had a higher prevalence of 
smoking (45.4%), alcohol drinking (13.6%), 
and betel nut chewing (13.6%), the differ-
ences by chi-square tests were insignificant.
Both the lead-exposed and nonexposed 
participants had normal neurologic imaging 
findings and no clinical evidence of neural 
diseases. The frontal gray and white matter 
of the lead-exposed group had a significantly 
lower Cho:tCr ratio than the nonexposed 
group. In the occipital lobe, all Cho:tCr ratios 
of gray, subcortical, and white matter in the 
lead-exposed group were significantly lower 
than those of the nonexposed group. That 
ratio in basal ganglions was also lower in the 
exposed group than in those measured in the 
nonexposed group, although not significant. 
Similarly, all the frontal lobe NAA:tCr ratios 
in the exposed group were lower than those of 
the nonexposed group. In the occipital lobe, 
only white matter in the exposed group had 
significantly lower NAA:tCr ratios compared 
with those of nonexposed. In the basal gan-
glion, the NAA:tCr ratios of those exposed to 
lead were significantly lower than those found 
in the controls (Table 2).
Table 3 shows the association between 
human brain MRS measurements and lead 
biomarkers (including blood, patella, and 
tibia lead) with 42 multiple regressions. The 
dependent variables were the MRS measure-
ments; the main predictors of interest to us 
were the lead biomarkers (blood, patella, and 
tibia lead levels), adjusting for sex, age, and 
smoking status (yes vs. no). Because the units 
of blood and bone lead levels were different, 
we compared effects using standardized 
regression coefficients in Table 3. Decreases 
in Cho:tCr ratios were significantly associated 
with increases in blood and bone lead levels, 
especially in the occipital lobe where all gray, 
subcortical, and white matter values were 
significant. These data suggest that Cho and 
Cho-containing compounds in the occipital 
lobe, compared with the other areas of brain, 
were the most sensitive to all blood and bone 
lead levels in these workers. However, the 
NAA:tCr ratios in every layer of the frontal 
brain were significantly inversely associated 
with blood and patella lead levels, suggesting 
that NAA in the frontal lobe might be the 
most sensitive to recent and subcumulative 
lead exposure. One of the strongest regres-
sion coefficients was –0.023 (SE = 0.005, 
p < 0.001, standardized coefficient = –0.764) 
for the NAA:tCr ratio in frontal gray matter 
and blood lead.
Discussion
This MRS study comparing the brain 
metabolism of middle-age workers chroni-
cally exposed to lead with matched nonex-
posed controls revealed a negative correlation 
between blood and bone lead and brain NAA 
and Cho levels, especially in the frontal and 
occipital lobes.
The effects of lead toxicity have been 
examined in the context of neurobehav-
ioral evaluations (Balbus-Kornfeld et al. 
1995; Chuang et al. 2005; Shih et al. 2007). 
Although the adverse effect of lead exposure 
on neurobehavioral functioning is one of 
the most consistently reported impairments 
associated with lead exposure, little is known 
Table 1. Characteristics of participants, and blood and bone lead levels.
Characteristic  Nonexposed (n = 18)  Exposed (n = 22)  p-Value
Age [years (mean ± SD)]  46.06 ± 10.14  45.71 ± 11.72  0.92a
Working duration [years (mean ± SD)]  —  12.95 ± 8.34 
BMI [kg/m2 (mean ± SD)]  24.48 ± 2.42  24.49 ± 3.07  0.99a
Lead     
  Blood [µg/dL (mean ± SD)]  3.40 ± 1.11  16.99 ± 10.38  < 0.001a
  Tibia [µg/g bone (mean ± SD)]  18.51 ± 22.40  61.55 ± 30.21  < 0.001a
  Patella [µg/g bone (mean ± SD)]  7.14 ± 9.81  66.29 ± 19.48  < 0.001a
Sex [n (%)]      0.731b
  Female   5 (27.8)  5 (22.7) 
  Male  13 (72.2)  17 (77.3) 
Years of education [n (%)]      0.788b
  ≤ 9   4 (22.2)  7 (31.8) 
  9–12   9 (50.0)  10 (45.5) 
  > 12   5 (27.8)  5 (22.7) 
Smoking [n (%)]      0.09b
  No  15 (83.3)  12 (54.5) 
  Yes  3 (16.7)  10 (45.5) 
Drinking [n (%)]      > 0.99b
  No  15 (83.3)  19 (86.4) 
  Yes  3 (16.7)  3 (13.6) 
Chew betel nut [n (%)]      0.613b
  No  17 (94.4)  19 (86.4) 
  Yes  1 (5.6)  3 (13.6) 
at-Test. bChi-square test.
Table 2. Comparisons of brain magnetic resonance between lead-exposed workers and the nonexposed 
group. 
  Nonexposed (n = 18)  Exposed (n = 22)
MRS measures   (mean ± SD)  (mean ± SD)  p-Valuea
Cho:tCr ratio
  Frontal lobe gray matter  1.430 ± 0.312  1.159 ± 0.121  0.002 
  Subcortical white matter  1.292 ± 0.273   1.198 ± 0.232   0.247 
  White matter  1.467 ± 0.222   1.276 ± 0.329   0.042 
  Basal ganglion  1.026 ± 0.183   1.017 ± 0.207   0.889 
  Occipital lobe gray matter   1.137 ± 0.240   0.805 ± 0.290   < 0.001
  Subcortical white matter   1.148 ± 0.239   0.821 ± 0.276   < 0.001
  White matter   1.417 ± 0.320   1.092 ± 0.369   0.006 
NAA:tCr ratio
  Frontal lobe gray matter  1.702 ± 0.314   1.390 ± 0.214   0.001 
  Subcortical white matter  1.566 ± 0.272   1.342 ± 0.185   0.004 
  White matter  1.684 ± 0.334   1.477 ± 0.297   0.046 
  Basal ganglion  1.107 ± 0.263   0.950 ± 0.199   0.038 
  Occipital lobe gray matter   1.543 ± 0.293   1.431 ± 0.405   0.331 
  Subcortical white matter   1.451 ± 0.237   1.290 ± 0.265   0.051 
  White matter   1.602 ± 0.306   1.162 ± 0.409   0.001
at-Test.Hsieh et al.
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about the effects of lead on brain metabolism 
in vivo or about the structural and functional 
correlates of lead-related brain dysfunction 
(Seeber et al. 2002). Thus, there has been a 
growing interest in the mechanisms through 
which lead affects brain function.
MRS is used widely to assess both neu-
ronal viability and demyelination and can 
detect both NAA and creatine in discrete 
tissue volumes. A decrease in NAA, which 
is located in neuronal cell bodies, has been 
proposed to indicate possible neuronal and 
axonal damage or loss, and, practically, the 
decrease in NAA is measured relative to the 
level of creatine, a stable metabolite whose 
level is constant after neuronal loss (van der 
Knaap et al. 1992). In the present study, we 
found a significant decline in NAA:tCr ratio 
in the presence of increased blood and patella 
lead levels in both the gray and white matter 
in the frontal lobe, an area of the brain that 
plays a critical role in the retrieval of source 
information. The memory component in the 
frontal lobe is more restricted to working 
memory, which is a component of executive 
function. This finding may help explain the 
lower memory task in neurobehavioral perfor-
mance in lead workers (Chuang et al. 2005; 
Schwartz et al. 2000, 2005; Seeber et al. 2002; 
Shih et al. 2007).
In the present study, the intensity of 
the Cho MRS signal was also reduced with 
increases in all blood and bone lead measures 
in the occipital lobe. The occipital lobe is the 
visual processing center of the mammalian 
brain and contains most of the anatomical 
region of the visual cortex. Lead exposure and 
exposed workers have indeed been found to 
have poor visuospatial/visuomotor domain 
processing on neurobehavioral tests (Schwartz 
et al. 2000, 2005; Seeber et al. 2002; Shih 
et al. 2007; Weisskopf et al. 2007b). A low 
Cho signal may indicate decreased cell mem-
brane turnover or myelin alterations that can 
lead to brain shrinkage (Cox 1996; Ross et al. 
2006). The findings of reduced Cho:tCr ratios 
in the exposure group were similar to the 
findings in the hepatic encephalopathy that 
may alter transport of Cho, decrease nutri-
tional uptake, and impair brain metabolism 
(Zwingmann 2007). These previous studies 
suggest that lead-induced neurotoxicity might 
alter the neural transmitters, although underly-
ing mechanisms are not clear. Changes of the 
neural transmitters may be one of the possible 
reasons for the reduction in Cho:tCr ratios.
In our study, reduced NAA:tCr and 
Cho:tCr ratios in the basal ganglia, the corti-
cal gray matter, the subcortical white matter, 
and the deep white matter suggests that lead-
induced encephalopathy affects the gray mat-
ter and the white matter in a similar manner 
and that closer attention should be paid to 
systemic influences. Reductions in the cortical 
gray matter and the subcortical white matter, 
both high-function areas of the brain, may 
explain at least in part the impaired cognitive 
functions previously reported in relation to 
lead exposure. The previous MRI studies sug-
gest that progressive and irreversible changes 
to the brain architecture may be caused by 
lead exposure (Schwartz et al. 2000; Stewart 
et al. 2006). The white matter changes in our 
study are consistent with these MRI findings.
Our study has several limitations. 
Technically, two-dimensional MRS can pro-
vide data from a larger region than can single-
voxel MRS. However, increased background 
noise made the myoinositol and the glutamate 
complex undetectable in our study. Recent 
improvements in hardware and software, 
which produce a better signal-to-noise ratio, 
may improve estimation in future two-dimen-
sional MRS studies. The small sample size is 
also a limitation affecting the power of this 
study. Only 22 lead workers in a small factory 
and 18 nonexposed volunteers participated in 
the MRS measurements. An extended study 
with larger screening might provide more 
information about the association between 
lead and brain damage.
In summary, lead toxicity to the human 
brain is complex and not well recognized. 
Our study showed that brain metabolism, 
especially NAA:tCr and Cho:tCr ratios, 
might be disturbed by lead. Brain NAA and 
Cho were negatively correlated with blood 
and bone lead levels, suggesting that lead 
may induce neuronal and axonal damage or 
loss. The most significant regions were frontal 
and occipital lobes, areas previously associ-
ated with impaired memory and visual per-
formance on neurobehavioral tests of people 
exposed to lead.
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